Products

See leaflet

Zanosar®
streptozocin

Indications

  • Zanosar® is indicated for the systemic treatment of adult patients with inoperable, advanced or metastatic, progressive and/or symptomatic, well-differentiated, G1 or G2 neuroendocrine tumours of pancreatic origin, in combination with 5-Fluorouracil

Presentations

  • (COMING SOON) Zanosar 1 g, powder for concentrate for solution for infusion.